• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

E-Prescribing Controlled Substances: The Time is NOW!

by Our Thought Leaders 06/04/2012 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Written by Irene Froehlich, Director of Marketing at DrFirst

The healthcare industry has been talking about the benefits of e-prescribing for years. By now, the advantages offered to your practice and your patients—through increased workflow efficiency and reduced medication errors—are obvious.

However,making e-prescribing for controlled substances (EPCS) available to physicians has proven to be more of a challenge. This has frustrated providers, patients, and loved ones of patients alike. In fact, one of our sales reps shared his family’s experience with me just the other day:

His father-in-law recently had surgery and was sent home with prescription pain medications. When he ran out of his medication on a Friday afternoon, our rep’s mother-in-law called their doctor’s office to obtain a prescription for a refill. The office was closing for the weekend, and the patient’s wife—who was at work at the time—couldn’t leave to pick up the prescription. As a result, the patient was without pain medication from Friday afternoon until Monday. He tried to control his pain with over the counter analgesics, but the medicine wasn’t strong enough: his father-in-law suffered until Monday when the prescription was picked up and refilled.

As upsetting as that story is, it’s not unique. But EPCS makes these types of situations obsolete. With EPCS, authorizing new prescriptions and renewals has become as easy as clicking through a few e-prescribing screens to make sure a script is correctly, safely, and securely processed.

 

Benefits of EPCS:

E-prescribing of controlled substances offers all the benefits of e-prescribing and more. The safeguards required for controlled substances are paired with software that allows you to pull a robust medication history for the patient and then check against current and past medications for drug/drug and drug/allergy interactions. EPCS software also helps doctors identify and prevent “doctor shopping” by those addicted to prescription drugs.

Security is Key:

In recent years, there has been a dramatic increase in prescription drug misuse or abuse. This increase has led to a corresponding increase in ER visits because of accidental overdoses as well as admissions to drug treatment programs for drug addictions.

Because of the safeguards necessary to avoid duplication of care and abuse of prescription medications, the Drug Enforcement Agency (DEA) has demanded extra security measures for e-prescribing of controlled substances. Doctors must be able to prove their identities at the point of prescribing and software vendors must assure their applications have appropriate controls and will pass third party audits. Pharmacies must ensure that the prescription is valid.

In 2010, the DEA gave approval for doctors to submit prescriptions for controlled substances to pharmacies electronically. DrFirst was first on the market with anEPCS GoldSM 2.0. This stand-alone system is DEA compliant and utilizes the Surescripts network to allow physicians to transmit prescriptions for controlled substances directly to participating pharmacies. Other vendors followed. Today 38 states as well as the District of Columbia have legalized electronically prescribed controlled substances

Getting Started with EPCS:

Controlled substances account for 20 percentof all prescriptions. And e-prescribing of controlled substances offers you and your patients another important safeguard in the use of controlled substances.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: e prescribing, e-prescribing of controlled substances, Electronic Prescribing of Controlled Substances, EPCS, EPCS Gold, Irene Froehlich, Patient Medication

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |